Drospirenone + Ethinylestradiol (Yasminelle ® and Yaz ®).

Drospirenone + Ethinylestradiol (Yasminelle ® and Yaz ®).
Product Description

Indication: Contraception - Approved and commercialized

Cyndea Pharma S.L

  • ES
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator

Cyndea Pharma S.L

  • ES
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator

More Products from Cyndea Pharma S.L (16)

  • Prednisone (Dacortin ®)

    Product Prednisone (Dacortin ®)

    Indication: Systemic glucocorticoid - Approved and commercialized
  • Softgels

    Product Softgels

    Indication: Contraception - Approved and commercialized
  • Tafamidis meglumine (Vyndaqel ®)

    Product Tafamidis meglumine (Vyndaqel ®)

    Indication: Transthyretin (TTR) amyloid polyneuropathy - Under Development
  • Ulipristal 5 mg ( Esmya ®)

    Product Ulipristal 5 mg ( Esmya ®)

    Indication: Uterine fibroids (myomas)Dossier ready for filing.
  • Contraception.

    Product Contraception.

    Cyndea Pharma S.L provides wide range of woman's health related products (hormones) which includes contraceptives. Contact us for more information.
  • Corticoids.

    Product Corticoids.

    Cyndea Pharma S.L provides wide range of corticosteroids. Contact us for more information.
  • Enzalutamide (Xtandi ®)

    Product Enzalutamide (Xtandi ®)

    Indication: Prostate Cancer - Under Development
  • Hormonal therapies.

    Product Hormonal therapies.

    Cyndea Pharma S.L provides wide range of woman's health related products (hormones) which includes hormonal therapies. Contact us for more information.
  • Hormones

    Product Hormones

    Cyndea Pharma S.L provides wide range of hormones. Contact us for more information.
  • Levonorgestrel + Ethinylestradiol (Loette ®).

    Product Levonorgestrel + Ethinylestradiol (Loette ®).

    Indication: Contraception - Approved and commercialized
  • Midostaurin (Rydapt ®)

    Product Midostaurin (Rydapt ®)

    Indication: Acute myeloid leukemia. Aggressive systemic mastocytosis - Under Development
  • Nintedanib  (Ofev ® / Vargatef ®)

    Product Nintedanib (Ofev ® / Vargatef ®)

    Indication: Idiopatic pulmonary fibrosis/ Non-Small Cell Lung Cancer - Ready for filing